| Chk1 inhibitor SCH900776 effectively potentiates the cytotoxic effects of platinum-based chemotherapeutic drugs in human colon cancer cells J Herůdková, K Paruch, P Khirsariya, K Souček, M Krkoška, OV Blanářová, ... Neoplasia 19 (10), 830-841, 2017 | 34 | 2017 |
| Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10 O Vondálová Blanářová, B Šafaříková, J Herůdková, M Krkoška, ... PloS one 12 (11), e0188584, 2017 | 26 | 2017 |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors J Svobodová, J Procházková, M Kabátková, M Krkoška, L Šmerdová, ... Toxicological Sciences 172 (2), 368-384, 2019 | 13 | 2019 |
| Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymes M Krkoška, J Svobodová, M Kabátková, O Zapletal, AH Vaculová, ... Toxicology 461, 152897, 2021 | 8 | 2021 |
| Inhibition of Chk1 stimulates cytotoxic action of platinum-based drugs and TRAIL combination in human prostate cancer cells M Krkoška, K Paruch, T Šošolíková, G Vázquez-Gómez, J Herůdková, ... Biological Chemistry, 2024 | | 2024 |
| EVALUATING METABOLOMIC PARAMETERS USING FLOW CYTOMETRY: A NOVEL APPROACH TO IDENTIFY AND CHARACTERIZE CANCER STEM CELLS M Krkoška, Z Tylichová, P Zatloukalová, B Vojtěšek, CP John | | 2023 |
| FLOW CYTOMETRIC ASSESSMENT OF METABOLIMIC PARAMETERS AS A NOVEL APPROACH FOR IDENTIFICATION AND CHARACTERIZATION OF CANCER STEM CELLS M Krkoška, Z Tylichová, P Zatloukalová, B Vojtěšek, PJ Coates | | 2023 |
| Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma M Krkoška, J Nekvindova, K Nevědělová, V Zubáňová, L Radová, ... Pharmacological Reports, 1-11, 2022 | | 2022 |
| CHK1 INHIBITOR SCH900776 ENHANCES ANTICANCER ACTION OF CISPLATIN AND TRAIL VIA STIMULATION OF BAK-DEPENDENT MITOCHONDRIAL PATHWAY M Krkoška, K Paruch, A Hyršlová Vaculová, J Herůdková | | 2021 |
| Inhibition of Chk1 enhances cooperative anticancer action of platinum-based drugs and TRAIL via activation of mitochondrial apoptotic pathway M Krkoška, J Herůdková, K Paruch, K Nevědělová, P Sova, ... | | 2019 |
| CHK1 INHIBITION FACILITATES THE COOPERATIVE ANTICANCER ACTION OF PLATINUM-BASED DRUGS AND TRAIL M Krkoška, J Herůdková, K Paruch, K Nevědělová, P Sova | | 2019 |
| INHIBITION OF P300/CBP REDUCES CYP1A1 INDUCTION IN CANCER CELL MODELS DERIVED FROM THE LIVER OR COLON EPITHELIUM M Krkoška, J Svobodová, O Zapletal, M Karasová, A Hyršlová Vaculová, ... | | 2018 |
| The role of Chk1 in regulation of apoptosis induced by platinum-based drugs in human prostate cancer cells M Krkoška, J Herůdková, OV Blanářová, K Paruch, P Sova, ... | | 2017 |
| INHIBITION OF CHK1 STIMULATES THE COOPERATIVE CYTOTOXIC ACTION OF PLATINUM-BASED DRUGS AND TRAIL IN HUMAN PROSTATE CANCER CELLS M Krkoška, J Herůdková, OV Blanářová, K Paruch, P Sova, ... | | 2017 |
| PLATINUM-BASED DRUG-MEDIATED INCREASE OF TRAIL-INDUCED PROSTATE CANCER CELL APOPTOSIS DEPENDS ON MITOCHONDRIA BUT NOT CASPASE-10 O Vondálová Blanářová, B Šafaříková, J Herůdková, M Krkoška, L Anděra, ... | | 2017 |
| Cisplatin or LA-12-mediated stimulation of TRAIL-induced apoptosis in human prostate cancer cells involves Bax/Bak-dependent mitochondria activation O Vondálová Blanářová, J Herůdková, B Šafaříková, M Krkoška, ... | | 2016 |
| Modulation of cytochrome c in cancer cells undergoing apoptosis and related mechanisms M Krkoška, J Herůdková, O Vondálová Blanářová, J Nekvindová, ... | | 2016 |
| Modulations of cytochrome c level in human colon cancer cells undergoing apoptosis induced by docosahexaenoic acid M Krkoška, B Skender, J Herůdková, J Hofmanová, J Nekvindová, ... | | 2015 |
| The specific changes in cytochrome c level induced by docosahexaenoic acid in colon cancer cells M Krkoška, B Skender, J Herůdková, J Hofmanová, J Nekvindová, ... | | 2015 |
